Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Tumor Immunotherapy01:27

Tumor Immunotherapy

520
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
520

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Correction: Lamadrid-González et al. <i>SMN2</i> Copy Number Association with Spinal Muscular Atrophy Severity: Insights from Colombian Patients. <i>J. Clin. Med.</i> 2024, <i>13</i>, 6402.

Journal of clinical medicine·2026
Same author

Natural Approaches to Appetite Suppression in Obesity: Mechanisms, Evidence, and Clinical Integration.

Nutrition reviews·2026
Same author

Arrhythmias in Dengue: A Systematic Review and Meta-Analysis.

Pathogens (Basel, Switzerland)·2026
Same author

Mechanical compression reduces CC16 expression and disrupts metabolic homeostasis in airway epithelial cells.

American journal of respiratory cell and molecular biology·2026
Same author

Polymer-Graphene Composites for Electrochemical Sensing: A Comprehensive Review of Functionalization Pathways and Sustainable Design Strategies.

Polymers·2026
Same author

Early Adverse Experiences and the Likelihood of Substance Use Disorders and Non-Fatal Overdose in Clinical and Community Settings: A Systematic Review and Meta-Analysis.

Behavioral sciences (Basel, Switzerland)·2026

相关实验视频

Updated: Jun 27, 2025

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
09:12

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

888

汽车T细胞在固体瘤中:克服障碍

Joselyn Rojas-Quintero1, María P Díaz2, Jim Palmar2

  • 1Medicine, Pulmonary, Critical Care, and Sleep Medicine Department, Baylor College of Medicine, Houston, TX 77030, USA.

International journal of molecular sciences
|April 27, 2024
PubMed
概括

化学抗原受体T细胞 (CAR T细胞) 疗法对固体瘤具有前景,但面临挑战. 研究探讨了通过改善向和克服瘤微环境来增强CAR T细胞对抗癌症的疗效的策略.

关键词:
癌症 癌症 癌症 癌症 癌症免疫疗法 免疫疗法固体瘤是一种固体瘤.

更多相关视频

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.3K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.4K

相关实验视频

Last Updated: Jun 27, 2025

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy
09:12

Author Spotlight: Advancements in Hypoxia-Sensitive CAR-T Therapy for Enhanced Cancer Immunotherapy

Published on: June 14, 2024

888
A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells
08:46

A Real-time Potency Assay for Chimeric Antigen Receptor T Cells Targeting Solid and Hematological Cancer Cells

Published on: November 12, 2019

53.3K
Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care
12:55

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

21.4K

科学领域:

  • 在瘤学瘤学.
  • 免疫治疗是一种免疫疗法.
  • 细胞疗法 细胞疗法

背景情况:

  • 化学抗原受体T细胞 (CAR T细胞) 疗法是血液癌症的成功采用细胞疗法.
  • 它在固体瘤中的应用受到诸如细胞贩运,在敌对瘤微环境中的生存和抗原识别等挑战的阻碍.

研究的目的:

  • 审查CAR T细胞疗法在固体瘤中的挑战.
  • 提出优化和新的方法,以提高CAR T细胞在固体癌症治疗中的疗效.

主要方法:

  • 关于对固体瘤进行CAR T细胞治疗的当前文献的综述.
  • 分析改善细胞局部化,生存和抗原识别的策略.

主要成果:

  • 固体瘤存在独特的挑战,包括瘤微环境的敌对性和抗原异质性.
  • 新兴的策略侧重于精确的细胞定位,微环境调制和自适应性抗原识别.

结论:

  • 克服目前的局限性对于释放CAR T细胞在固体瘤中的全部治疗潜力至关重要.
  • 对先进的CAR T细胞设计和输送方法的持续研究对于临床成功至关重要.